Raymond V. Gilmartin
Raymond V. Gilmartin "is the former Chairman, President and Chief Executive Officer of Merck & Co., Inc., a global research-driven pharmaceutical company that discovers, develops, manufactures and markets innovative vaccines and medicines. In July 2006, he joined the faculty at the Harvard Business School as Professor of Management Practice teaching in the MBA program.
"Mr. Gilmartin joined Merck as President and Chief Executive Officer in June 1994, was named to the additional position of Chairman of the Board in November 1994. He served in those capacities until May 2005 when he relinquished those titles as part of the succession planning process leading up to his planned retirement in April 2006. In the interim, he served as Special Advisor to the Executive Committee of the Board of Directors.
"Prior to joining Merck, Mr. Gilmartin served as Chairman, President and CEO of Becton Dickinson, a global company that develops, manufactures and markets medical devices and diagnostic products. He joined that company in 1976 as vice president, strategic planning, and took on positions of increasing responsibility over the next eighteen years.
"An active participant in health industry affairs worldwide, Mr. Gilmartin is a stakeholder in the Harvard Program for Health System Improvement, is a past chair of the Healthcare Leadership Council and was a board member of the Alliance for Healthcare Reform. In addition, he is a past chair of the Pharmaceutical Research and Manufacturers of America and a past president of the International Federation of the Pharmaceutical Manufacturers Associations.
"Mr. Gilmartin also has been involved in global economic and trade issues that concern the pharmaceutical industry. He was a member of the President’s Export Council and is a past chair of the Council on Competitiveness. He was a member of the Transatlantic Business Dialogue and of the Trade and Poverty Forum, a project of the German Marshall Fund." 
Resources and articles
- Raymond V. Gilmartin, Microsoft, accessed December 9, 2007.